Children’s vaccines do not induce cross reactivity against SARS-CoV
In contrast with adults, children infected by severe acute respiratory syndrome-corona virus (SARS-CoV) develop milder clinical symptoms. Because of this, it is speculated that children vaccinated with various childhood vaccines might develop cross immunity against SARS-CoV. Antisera and T cells fro...
Saved in:
Published in: | Journal of clinical pathology Vol. 60; no. 2; pp. 208 - 211 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
BMJ Publishing Group Ltd and Association of Clinical Pathologists
01-02-2007
BMJ BMJ Publishing Group LTD BMJ Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In contrast with adults, children infected by severe acute respiratory syndrome-corona virus (SARS-CoV) develop milder clinical symptoms. Because of this, it is speculated that children vaccinated with various childhood vaccines might develop cross immunity against SARS-CoV. Antisera and T cells from mice immunised with various vaccines were used to determine whether they developed cross reactivity against SARS-CoV. The results showed no marked cross reactivity against SARS-CoV, which implies that the reduced symptoms among children infected by SARS-CoV may be caused by other factors. |
---|---|
Bibliography: | istex:7E7CEB6A9DD25B89313166206CE8FF6D85E99E28 PMID:17264247 Correspondence to: Dr B Wang State Key Laboratory for Agro-Biotechnology, College of Biological Science, China Agricultural University, 2 Yuanmingyuan Xi Road, Beijing 100094, China; bwang3@cau.edu.cn ark:/67375/NVC-TJLTHM4J-2 local:0600208 href:jclinpath-60-208.pdf ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0021-9746 1472-4146 |
DOI: | 10.1136/jcp.2006.038893 |